Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
40
SIGA Quote, Financials, Valuation and Earnings
Last price:
$6.27
Seasonality move
:
14.13%
Day range:
$6.21 - $6.33
52-week range:
$4.95 - $9.62
Dividend yield:
0%
P/E ratio:
6.02x
P/S ratio:
2.60x
P/B ratio:
2.21x
Volume:
318.5K
Avg. volume:
375.3K
1-year change:
3.47%
Market cap:
$449M
Revenue:
$138.7M
EPS (TTM):
$1.04
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
-- | -- | -- | -- | -- |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
NNVC
NanoViricides, Inc.
|
-- | -$0.08 | -- | -42.49% | $6.50 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.38 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
$6.27 | -- | $449M | 6.02x | $0.60 | 0% | 2.60x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$4.85 | $0.85 | $611.2M | 8.15x | $0.80 | 0% | 9.42x |
|
NNVC
NanoViricides, Inc.
|
$1.19 | $6.50 | $21.4M | -- | $0.00 | 0% | -- |
|
OGEN
Oragenics, Inc.
|
$0.86 | $2.00 | $706.9K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.19 | $7.00 | $6.5M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
0.43% | 1.632 | 0.13% | 7.02x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
NNVC
NanoViricides, Inc.
|
-- | 0.464 | -- | 0.95x |
|
OGEN
Oragenics, Inc.
|
3.86% | -0.075 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -3.365 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SIGA
SIGA Technologies, Inc.
|
$1.6M | -$10.2M | 36.5% | 36.71% | -390.18% | -$10.1M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
NNVC
NanoViricides, Inc.
|
-$132.8K | -$1.8M | -92.29% | -92.29% | -- | -$1.7M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
SIGA Technologies, Inc. vs. Competitors
-
Which has Higher Returns SIGA or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of -255.85%. SIGA Technologies, Inc.'s return on equity of 36.71% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About SIGA or NBY?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -82.47%. Given that NovaBay Pharmaceuticals, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe NovaBay Pharmaceuticals, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is SIGA or NBY More Risky?
SIGA Technologies, Inc. has a beta of 0.980, which suggesting that the stock is 1.989% less volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock SIGA or NBY?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or NBY?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. SIGA Technologies, Inc.'s net income of -$6.4M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.02x while NovaBay Pharmaceuticals, Inc.'s PE ratio is 8.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.60x versus 9.42x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.60x 6.02x $2.6M -$6.4M NBYNovaBay Pharmaceuticals, Inc.9.42x 8.15x $521K -$1.3M
-
Which has Higher Returns SIGA or NNVC?
NanoViricides, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 36.71% beat NanoViricides, Inc.'s return on equity of -92.29%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M NNVCNanoViricides, Inc.-- -$0.10 $7.2M -
What do Analysts Say About SIGA or NNVC?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NanoViricides, Inc. has an analysts' consensus of $6.50 which suggests that it could grow by 446.22%. Given that NanoViricides, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe NanoViricides, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 NNVCNanoViricides, Inc.1 0 0 -
Is SIGA or NNVC More Risky?
SIGA Technologies, Inc. has a beta of 0.980, which suggesting that the stock is 1.989% less volatile than S&P 500. In comparison NanoViricides, Inc. has a beta of 1.158, suggesting its more volatile than the S&P 500 by 15.816%.
-
Which is a Better Dividend Stock SIGA or NNVC?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. NanoViricides, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. NanoViricides, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or NNVC?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than NanoViricides, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$6.4M is lower than NanoViricides, Inc.'s net income of -$1.8M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.02x while NanoViricides, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.60x versus -- for NanoViricides, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.60x 6.02x $2.6M -$6.4M NNVCNanoViricides, Inc.-- -- -- -$1.8M
-
Which has Higher Returns SIGA or OGEN?
Oragenics, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 36.71% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About SIGA or OGEN?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 132.83%. Given that Oragenics, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Oragenics, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 OGENOragenics, Inc.1 0 0 -
Is SIGA or OGEN More Risky?
SIGA Technologies, Inc. has a beta of 0.980, which suggesting that the stock is 1.989% less volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.781%.
-
Which is a Better Dividend Stock SIGA or OGEN?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or OGEN?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than Oragenics, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$6.4M is lower than Oragenics, Inc.'s net income of -$3.1M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.02x while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.60x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.60x 6.02x $2.6M -$6.4M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns SIGA or PTN?
Palatin Technologies has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 36.71% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M PTNPalatin Technologies-- -- -- -
What do Analysts Say About SIGA or PTN?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than SIGA Technologies, Inc., analysts believe Palatin Technologies is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 PTNPalatin Technologies0 0 0 -
Is SIGA or PTN More Risky?
SIGA Technologies, Inc. has a beta of 0.980, which suggesting that the stock is 1.989% less volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock SIGA or PTN?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or PTN?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than Palatin Technologies quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$6.4M is higher than Palatin Technologies's net income of --. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.02x while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.60x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.60x 6.02x $2.6M -$6.4M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns SIGA or TOVX?
Theriva Biologics, Inc. has a net margin of -242.97% compared to SIGA Technologies, Inc.'s net margin of --. SIGA Technologies, Inc.'s return on equity of 36.71% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital SIGASIGA Technologies, Inc.61.75% -$0.09 $204.4M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About SIGA or TOVX?
SIGA Technologies, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3559.17%. Given that Theriva Biologics, Inc. has higher upside potential than SIGA Technologies, Inc., analysts believe Theriva Biologics, Inc. is more attractive than SIGA Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SIGASIGA Technologies, Inc.0 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is SIGA or TOVX More Risky?
SIGA Technologies, Inc. has a beta of 0.980, which suggesting that the stock is 1.989% less volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.818%.
-
Which is a Better Dividend Stock SIGA or TOVX?
SIGA Technologies, Inc. has a quarterly dividend of $0.60 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SIGA Technologies, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SIGA or TOVX?
SIGA Technologies, Inc. quarterly revenues are $2.6M, which are larger than Theriva Biologics, Inc. quarterly revenues of --. SIGA Technologies, Inc.'s net income of -$6.4M is lower than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, SIGA Technologies, Inc.'s price-to-earnings ratio is 6.02x while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SIGA Technologies, Inc. is 2.60x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SIGASIGA Technologies, Inc.2.60x 6.02x $2.6M -$6.4M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 29
Galecto, Inc. [GLTO] is down 0.67% over the past day.
Sell
20
SMX alert for Dec 29
SMX (Security Matters) Plc [SMX] is down 24.92% over the past day.
Sell
11
CDNAF alert for Dec 29
Canadian Tire Corp. Ltd. [CDNAF] is up 11.36% over the past day.
